Recent evidence has shown that a single-dose schedule can provide comparable efficacy to the two-dose regimen. A single-dose schedule could rapidly increase HPV vaccination rollout and access.
Resources on this page provide guidance and insights into the adoption of single-dose HPV vaccine schedules. The types of documents you may find in the table are:
- Global Guidelines: WHO and other global recommendations.
- Country-Specific Case Studies: Examples of countries implementing single-dose schedules.
- Programmatic Implications: Detailed analysis of programmatic impacts (e.g., vaccine schedule optimization).
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Review of Existing Evidence on Single-Dose HPV Vaccination | Single dose consortium | 2022 | Presentation | English, French |
| HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation | PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health | 2023 | Guidance | English, French, Portuguese, Russian, Spanish |
| Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second Edition | World Health Organization (WHO) | 2024 | Guidance | English |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | PATH | 2025 | Report | English |